Healthcare

How pleased are pharmacists with BC PharmaCare's recent decision to pay $1 more for less patient care? Pleased doesn't begin to describe it. Not at all. And how many ways will patient care be impacted? Let me count the ways.

The ads by Heart & Stroke put a human face on the impact of research into cardiovascular and cerebrovascular disorders.

‘The continued reliance on outdated, paper- and fax-based prescribing systems introduces significant risks, contributing to medication errors, privacy breaches and administrative burdens that compromise patient care and place undue strain on clinicians,’ the study's authors write.

Two clinicians wonder why dual orexin receptor antagonists don’t get covered by Canada’s provincial drug plans.

The city’s executive policy committee approved Tuesday a motion from Mayor Scott Gillingham for his office to work with a consulting firm to outline how a proposed Winnipeg Community Response Service could work with community partners, health-system supports and the city’s 911 operations.

Licensed in 2003, BabyBIG is the brand name for human botulism immune globulin, an IV medication that uses antibodies from volunteers vaccinated against botulism to help babies too young to fight the disease on their own.

Dr. Marcia Anderson spearheaded the project to begin voluntary collection of this data across the province.

Get the info you need on these new products, part of our drug news roundup for December.